NCT05407480 Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
| NCT ID | NCT05407480 |
| Status | Recruiting |
| Phase | — |
| Sponsor | French Africa Pediatric Oncology Group |
| Condition | Staging |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2022-11-15 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2022-11-15 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.
Eligibility Criteria
Inclusion Criteria: under 18 years of age at diagnosis * suffering from "classical" Hodgkin's disease according to the WHO classification. * with no history of hematological malignancies or constitutional or acquired immune deficiencies Exclusion Criteria: * Over 18 years of age at diagnosis * A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies
Contact & Investigator
FATEN Ben Ayed, Professeur
PRINCIPAL INVESTIGATOR
French Africa Pediatric Oncology Group
Frequently Asked Questions
Who can join the NCT05407480 clinical trial?
This trial is open to participants of all sexes, aged 0 Months or older, up to 18 Years, studying Staging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05407480 currently recruiting?
Yes, NCT05407480 is actively recruiting participants. Contact the research team at brenda.mallon@gustaveroussy.fr for enrollment information.
Where is the NCT05407480 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT05407480 clinical trial?
NCT05407480 is sponsored by French Africa Pediatric Oncology Group. The principal investigator is FATEN Ben Ayed, Professeur at French Africa Pediatric Oncology Group. The trial plans to enroll 250 participants.